Department of Chemical and Biological Engineering, University of Colorado, Boulder, 3415 Colorado Avenue, Boulder, CO, 80303, USA.
Department of Chemical and Biological Engineering, University of Colorado, Boulder, 3415 Colorado Avenue, Boulder, CO, 80303, USA.
Metab Eng. 2023 May;77:118-127. doi: 10.1016/j.ymben.2023.03.008. Epub 2023 Mar 22.
Cells build fatty acids in tightly regulated assembly lines, or fatty acid synthases (FASs), in which β-ketoacyl-acyl carrier protein (ACP) synthases (KSs) catalyze sequential carbon-carbon bond forming reactions that generate acyl-ACPs of varying lengths-precursors for a diverse set of lipids and oleochemicals. To date, most efforts to control fatty acid synthesis in engineered microbes have focused on modifying termination enzymes such as acyl-ACP thioesterases, which release free fatty acids from acyl-ACPs. Changes to the substrate specificity of KSs provide an alternative-and, perhaps, more generalizable-approach that focuses on controlling the acyl-ACPs available for downstream products. This study combines mutants of FabF and FabB, the two elongating KSs of the E. coli FAS, with in vitro and in vivo analyses to explore the use of KS mutants to control fatty acid synthesis. In vitro, single amino acid substitutions in the gating loop and acyl binding pocket of FabF shifted the product profiles of reconstituted FASs toward short chains and showed that KS mutants, alone, can cause large shifts in average length (i.e., 6.5-13.5). FabB, which is essential for unsaturated fatty acid synthesis, blunted this effect in vivo, but exogenously added cis-vaccenic acid (C18:1) enabled sufficient transcriptional repression of FabB to restore it. Strikingly, a single mutant of FabB afforded titers of octanoic acid as high as those generated by an engineered thioesterase. Findings indicate that fatty acid synthesis must be decoupled from microbial growth to resolve the influence of KS mutants on fatty acid profiles but show that these mutants offer a versatile approach for tuning FAS outputs.
细胞在严格调控的组装线(脂肪酸合酶,FAS)中合成脂肪酸,其中β-酮酰-酰基载体蛋白(ACP)合酶(KS)催化连续的碳-碳键形成反应,生成不同长度的酰基-ACP——这是各种脂质和油脂化学品的前体。迄今为止,大多数控制工程微生物中脂肪酸合成的努力都集中在修饰终止酶上,例如酰基-ACP 硫酯酶,它从酰基-ACP 中释放出游离脂肪酸。KS 底物特异性的改变提供了一种替代方法,也许更具普遍性,它侧重于控制可用于下游产品的酰基-ACP。本研究结合了 FabF 和 FabB 的突变体,即大肠杆菌 FAS 的两个延伸 KS,通过体外和体内分析来探索使用 KS 突变体来控制脂肪酸合成。在体外,FabF 门控环和酰基结合口袋中的单个氨基酸取代改变了重组 FAS 的产物谱,使其向短链转移,并表明 KS 突变体本身就可以引起平均长度的巨大变化(即 6.5-13.5)。对于不饱和脂肪酸合成必不可少的 FabB 在体内削弱了这种效应,但外源性添加顺式-蓖麻酸(C18:1)使 FabB 的转录抑制足以恢复其功能。引人注目的是,FabB 的一个单一突变体使辛酸的产量高达工程硫酯酶产生的产量。研究结果表明,必须将脂肪酸合成与微生物生长解耦,以解决 KS 突变体对脂肪酸谱的影响,但表明这些突变体为调整 FAS 输出提供了一种通用方法。